Lam Research Corporation (LRCX) rises 6.6% on UBS target hike
Lam Research Corporation (LRCX) rises sharply after UBS lifted its price target, adding fuel to a rally already driven by strong earnings, upbeat AI-chip demand, and higher wafer fab equipment spending expectations. The stock is now trading near its 52-week high as investors weigh momentum against a richer valuation.
Lam Research Corporation (LRCX) rises 6.6% as a fresh UBS price-target increase reinforces an already strong post-earnings rally. The move reflects improving sentiment around AI chip demand, higher wafer fab equipment spending, and Lam’s continued execution, but the stock’s rich valuation means investors should expect more selective upside from here.
Lam Research Corporation (LRCX) rises sharply today, climbing 6.63% to $345.96 at 10:00 ET and pushing up against its 52-week high of $346.19. The move matters because it extends a powerful semiconductor equipment rally and follows a fresh analyst target increase that adds fuel to an already strong post-earnings trend.
Key Takeaways
LRCX is up 6.63% today at 10:00 ET, trading near its 52-week high of $346.19.
The clearest same-day catalyst is UBS raising its price target to $375 from $310 on June 9.
The rally also builds on Lam Research's April 22 fiscal Q3 beat, including $5.84B in revenue and non-GAAP EPS of $1.47 versus a $1.36 estimate.
Analyst sentiment has stayed bullish, with Morgan Stanley upgrading LRCX to Overweight on May 18 and multiple firms lifting targets after earnings.
For investors, the move reinforces that Lam is being valued as both an AI infrastructure beneficiary and a wafer fab equipment leader, though the stock now trades at 61.33x earnings.
Why Lam Research Corporation Stock Rises Today
The most concrete catalyst behind today’s move is a new analyst action. UBS raised its price target on Lam Research (LRCX) to $375 from $310 on June 9 while maintaining a Buy rating. When a stock is already near a breakout level, a same-day target hike can act like a second ignition switch.
That call landed on a stock that already had momentum. LRCX has been riding a strong trend since its April 22 fiscal Q3 2026 report, when Lam posted record revenue of $5.84B and non-GAAP EPS of $1.47. Earnings history shows that EPS beat the $1.36 consensus by 8.1%, extending a streak of seven straight quarterly beats.
Just as important, Lam guided the June quarter to $6.60B plus or minus $400M in revenue and $1.65 plus or minus $0.15 in non-GAAP EPS. It also raised its 2026 wafer fabrication equipment spending outlook to about $140B from $135B. That is the kind of number that gets the market’s attention, because it points to stronger customer spending across the chip manufacturing chain.
AI Demand and Chip Equipment Strength Keep LRCX in Favor
Today’s rally is not happening in isolation. Semiconductor stocks recovered after the prior session’s selloff, and market coverage tied the rebound to renewed confidence in the AI buildout. One report noted that Nvidia CEO Jensen Huang described the earlier pullback as a chance to buy at a discount, helping stabilize sentiment across chip names.
That backdrop matters for Lam Research because the company sells the tools used to build advanced chips. Its systems support etch, deposition, wafer processing, and advanced packaging. As AI chips become more complex, chipmakers need more manufacturing steps and tighter process control. That dynamic has helped lift the whole semiconductor equipment group, including Applied Materials, KLA, ASML, and Lam.
Lam has also leaned into that narrative directly. Reuters reported on May 21 that the company is adding sensing and AI capabilities to its manufacturing tools and expanding operations in Arizona and California. In plain English, Lam is not just selling picks and shovels into AI. It is upgrading the picks and shovels too.
Lam Research Financials Show Strength, but Valuation Is Rich
The fundamental backdrop is strong. Lam carries a market cap of $432.65B, generated trailing EPS of 5.29, and has beaten earnings estimates in each of the last seven reported quarters. That consistency matters in a cyclical industry where investor confidence can vanish fast when order trends soften.
However, the valuation is no longer modest. LRCX trades at 61.33x earnings, which is a premium multiple even in a market that pays up for AI-linked names. The stock also sits just below its 52-week high after rising from a 52-week low of $87.3285. That is a huge re-rating in a short period.
Analysts have responded by moving targets higher rather than backing away. Besides today’s UBS increase to $375, Wells Fargo raised its target to $365 from $320 on June 1, Mizuho lifted its target to $380 from $330 on May 27, and Morgan Stanley upgraded the stock to Overweight from Underweight on May 18. Consensus still shows a Buy rating, with 39 Buy ratings, 10 Holds, and 1 Sell.
That pattern tells an important story. Wall Street is adjusting upward as Lam keeps delivering better numbers and stronger industry signals. Still, when price targets chase a fast-moving stock, upside can become more selective than automatic.
The cleanest read is that Lam Research is benefiting from three forces at once: a fresh UBS target hike, strong momentum from its April earnings beat, and a broader return to AI and semiconductor equipment stocks. Those forces can reinforce each other, especially in a high-beta stock with a beta of 1.868.
For momentum investors, the stock’s push to a new high zone keeps the trend intact. For valuation-focused investors, the setup is less forgiving because a 61.33x P/E leaves less room for disappointment. In other words, Lam still has operating strength on its side, but the stock price now demands that strength keep showing up in the numbers.
News sentiment also remains supportive overall. Quantified sentiment over the last 30 days stands at 0.4132 and over 90 days at 0.6538, both positive readings. Even with a deteriorating trend over the last week, the broader tone around LRCX remains constructive rather than broken.
Lam Research (LRCX) rises today because a fresh UBS price-target increase hit a stock that was already running on strong earnings, higher capex expectations, and renewed AI-chip enthusiasm. The business momentum is real, but so is the richer valuation, which means future gains will need continued execution rather than just a hot narrative.
LRCX is rising after UBS raised its price target to $375 from $310 and kept a Buy rating. The move also builds on Lam Research’s strong April earnings beat and ongoing optimism around AI-related chip equipment demand.
+Should I buy LRCX stock now?
Lam Research has strong momentum and solid fundamentals, but the stock is already trading near its 52-week high and at a rich valuation. That makes it more suitable for investors comfortable buying strength than for those looking for a bargain entry.
+What was the main catalyst for Lam Research's move higher?
The clearest same-day catalyst was UBS lifting its price target on Lam Research while maintaining a Buy rating. That came on top of recent earnings strength and multiple analyst upgrades over the past few weeks.
+Is Lam Research benefiting from AI demand?
Yes. Lam Research is benefiting from the broader AI infrastructure buildout because its tools are used in advanced chip manufacturing. Higher spending on semiconductor equipment has helped support the stock’s recent rally.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on LRCX?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
